Synapse - Roni Tamari

Search Within

Roni Tamari

Results (213)

A multi-center collaborative study of outcomes of TP53- mutated MDS/AML patients following allogeneic HCT

Meeting Abstract

Byrne, M.; Kurian, T.; Patel, D.; Tamari, R.; Hong, S.; Abdelhakim, H.; Klein, V.; Rojas, P.; Madhavan, R.; Kent, A; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Double unit cord blood transplantation compares favorably to T-cell depleted matched adult donor transplantation for the treatment of acute leukemia due to a robust protection against relapse

Meeting Abstract

Politikos, I.; Flynn, J.; Devlin, S. M.; Fingrut, W.; Maloy, M. A.; Naputo, K.; Chinapen, S.; Rodriguez, N. T.; Quach, S.; Dominguez, Y.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Phase II trial of eprenetapopt (APR-246) in combination with azacitidine (AZA) as maintenance therapy for TP53 mutated acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) following allogeneic hematopoietic cell transplantation (HCT)

Meeting Abstract

Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M.; Gooptu, M.; Bin, C.; Deeg, J.; Gallacher, P.; Wennborg, A.; Kaylor Hickman, D.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Outcomes of refractory cytomegalovirus infection in the first year after allogeneic hematopoietic cell transplantation

Journal Article

Karantoni, E.; Zavras, P. D.; Su, Y.; Fang, J.; Tamari, R.; Cho, C.; Perales, M. A.; Stern, A.; Papanicolaou, G. A.
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation

Journal Article

Lin, A.; Brown, S.; Maloy, M.; Ruiz, J. D.; Devlin, S.; DeRespiris, L.; Proli, A.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; more...
Leukemia and Lymphoma (2022)

Fulltext@MSK | Save

Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant

Journal Article

Sola, M.; Bhatt, V.; Palazzo, M.; Cavalier, K. E.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D.; Dahi, P. B.; more...
Bone Marrow Transplantation (2022)

Fulltext@MSK | Save

CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis

Journal Article

Nawas, M. T.; Lee, J. O.; Flynn, J.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Cho, C.; Ponce, D. M.; Sauter, C. S.; Perales, M. A.; more...
Bone Marrow Transplantation (2022)

Fulltext@MSK | Save

Population pharmacokinetics of melphalan in a large cohort of autologous and allogeneic hematopoietic cell transplantation recipients: Towards individualized dosing regimens

Journal Article

Shah, G. L.; Boelens, J. J.; Carlow, D.; Lin, A.; Schofield, R.; Cruz Sitner, N.; Alperovich, A.; Ruiz, J.; Proli, A.; Dahi, P.; more...
Clinical Pharmacokinetics (2022)

Fulltext@MSK | Save

The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT

Journal Article

Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
Blood Advances (2022)

Fulltext@MSK | Save

Adding centralized electronic patient-reported outcome data collection to an established international clinical outcomes registry

Journal Article

Cusatis, R.; Flynn, K. E.; Vasu, S.; Pidala, J.; Muffly, L.; Uberti, J.; Tamari, R.; Mattila, D.; Mussetter, A.; Bruzauskas, R.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save